Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirsh

Showing results (361-370 of 2,960) with videos related to

Pageof 296
Sort By:
Shock (Augusta, Ga.)|August 18, 2001
Overexpression of the high-affinity Fcgamma receptor (CD64) is associated with leukocyte dysfunction in sepsisM Hirsh, E Mahamid, Y Bashenko, et al.
ACP Journal Club|July 3, 2002
Review: extended out-of-hospital prophylaxis with heparin prevents deep venous thrombosis in elective hip arthroplastyMartin O'Donnell, Jack Hirsh
Progress in Cardiovascular Diseases|March 1, 1975
Observations in anticoagulant and thrombolytic therapy in pulmonary embolismE Genton, J Hirsh
Medicina|December 15, 2011
[Diagnosis of deep vein thrombosis by invasive and non invasive methods]A Zielinsky, J Hirsh
Seminars in Thrombosis and Hemostasis|April 1, 1987
Optimal dosage regimens of tissue-type plasminogen activatorG Agnelli, J Hirsh
Circulation|June 15, 1996
Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart AssociationJ Hirsh, J Hoak
Harefuah|October 1, 1996
[Dry-eye syndrome--background and treatment modalities]A Hirsh, M Belkin
The New England Journal of Medicine|May 22, 1997
Management of anticoagulation before and after elective surgeryC Kearon, J Hirsh
Seminars in Thrombosis and Hemostasis|January 1, 1997
Low-molecular-weight heparin for the out-of-hospital treatment of venous thrombosis: rationale and clinical resultsM Crowther, J Hirsh
Developmental Biology|March 1, 1976
Temperature-sensitive zygote defective mutants of Caenorhabditis elegansR Vanderslice, D Hirsh
Pageof 296

Showing results (361-370 of 2,960) with videos related to

Sort By:
Pageof 296
Shock (Augusta, Ga.)|August 18, 2001
Overexpression of the high-affinity Fcgamma receptor (CD64) is associated with leukocyte dysfunction in sepsisM Hirsh, E Mahamid, Y Bashenko, et al.
ACP Journal Club|July 3, 2002
Review: extended out-of-hospital prophylaxis with heparin prevents deep venous thrombosis in elective hip arthroplastyMartin O'Donnell, Jack Hirsh
Progress in Cardiovascular Diseases|March 1, 1975
Observations in anticoagulant and thrombolytic therapy in pulmonary embolismE Genton, J Hirsh
Medicina|December 15, 2011
[Diagnosis of deep vein thrombosis by invasive and non invasive methods]A Zielinsky, J Hirsh
Seminars in Thrombosis and Hemostasis|April 1, 1987
Optimal dosage regimens of tissue-type plasminogen activatorG Agnelli, J Hirsh
Circulation|June 15, 1996
Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart AssociationJ Hirsh, J Hoak
Harefuah|October 1, 1996
[Dry-eye syndrome--background and treatment modalities]A Hirsh, M Belkin
The New England Journal of Medicine|May 22, 1997
Management of anticoagulation before and after elective surgeryC Kearon, J Hirsh
Seminars in Thrombosis and Hemostasis|January 1, 1997
Low-molecular-weight heparin for the out-of-hospital treatment of venous thrombosis: rationale and clinical resultsM Crowther, J Hirsh
Developmental Biology|March 1, 1976
Temperature-sensitive zygote defective mutants of Caenorhabditis elegansR Vanderslice, D Hirsh
Pageof 296